Tempest Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPST and other ETFs, options, and stocks.About TPST
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients.
TPST Key Statistics
Stock Snapshot
The current Tempest Therapeutics(TPST) stock price is $2.42, with a market capitalization of 32.34M. The stock trades at a price-to-earnings (P/E) ratio of -0.23.
On 2026-02-13, Tempest Therapeutics(TPST) stock traded between a low of $2.26 and a high of $2.42. Shares are currently priced at $2.42, which is +7.1% above the low and 0.0% below the high.
Tempest Therapeutics(TPST) shares are trading with a volume of 17.98K, against a daily average of 204.43K.
In the last year, Tempest Therapeutics(TPST) shares hit a 52-week high of $12.37 and a 52-week low of $2.16.
In the last year, Tempest Therapeutics(TPST) shares hit a 52-week high of $12.37 and a 52-week low of $2.16.
TPST News
Tempest Therapeutics ( (TPST) ) just unveiled an announcement. On February 11, 2026, Tempest Therapeutics announced it would post an updated corporate presenta...
An announcement from Tempest Therapeutics ( (TPST) ) is now available. On January 20, 2026, Tempest Therapeutics announced that its board set January 30, 2026...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.